Tech Company Financing Transactions
Corvia Medical Funding Round
Private investors participated in a $54 million funding round for Corvia Medical. This venture round was announced on 6/9/2022.
Transaction Overview
Company Name
Announced On
6/9/2022
Transaction Type
Venture Equity
Amount
$54,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Funds will be utilized to support a confirmatory trial that builds on the extensive data and progressive learnings from the REDUCE LAP-HF II clinical trial of the Corvia® Atrial Shunt in heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1 Highwood Dr. 300
Tewksbury, MA 01876
USA
Tewksbury, MA 01876
USA
Phone
Website
Email Address
Overview
Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world's first transcatheter device designed to treat heart failure with preserved ejection fraction (HFpEF), previously known as diastolic heart failure (DHF).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Fazio
Chief Medical Officer
Jan Komtebedde
VP - R & D
Ed McNamara
VP - Regulatory Affairs
Kate Stohlman
Browse more venture capital transactions:
Prev: 6/9/2022: Brown Foods venture capital transaction
Next: 6/9/2022: Peptone venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs